期刊文献+

肿瘤最小ADC值在胶质瘤分级中的应用研究 被引量:13

Diagnostic Value of Minimum Apparent Diffusion Coefficient in Grading of Gliomas
下载PDF
导出
摘要 目的:评价肿瘤最小ADC值在胶质瘤分级中的应用价值。方法:回顾性分析81例经病理证实的胶质瘤患者常规MRI及DWI资料,其中低级别胶质瘤31例(Ⅰ级3例、Ⅱ级28例),高级别胶质瘤50例(Ⅲ级21例、Ⅳ级29例)。在ADC图上测量肿瘤组织最小ADC值。统计学方法应用成组t检验、单因素方差分析以及Spearman相关性分析。结果:低级别胶质瘤平均最小ADC值[(1.279±0.270)×10-3mm2/s]高于高级别胶质瘤平均最小ADC值[(0.849±0.185)×10-3mm2/s](P<0.001),高于Ⅲ级胶质瘤平均最小ADC值[(0.92±0.201)×10-3mm2/s](P<0.001),也高于Ⅳ级胶质瘤平均最小ADC值[(0.797±0.156)×10-3mm2/s](P<0.001),但Ⅲ级与Ⅳ级胶质瘤平均最小ADC值无统计学差异(P=0.069)。肿瘤最小ADC值与胶质瘤级别呈显著负相关(r=-0.699,P<0.001)。结论:肿瘤最小ADC值有助于胶质瘤分级诊断。 Purpose: To assess the utility of the minimum apparent diffusion coefficient (minADC) for grading gliomas. Methods: Findings from 81 patients with pathologically proven gliomas that included 31 low grade gliomas (LGG) (grade I: 3; grade II: 28) and 50 high grade gliomas (HGG) (grade III: 21; grade IV: 29) were analyzed retrospectively. The minADC value of each tumor was determined from several regions of interest defined in the tumor on ADC maps correlation analysis were used for statistical evaluation Student t test, one-way ANOVA and Spearman Results: The mean value of minADC for LGGs [(1.279 ± 0.270)×10-3mm2/s] was higher than that of HGGs [(0.849 ± 0.185) ×10-3mm2/s] (P〈0.001). The mean value of minADC showed significant differences between LGG, grade Ill [(0.92±0.201)×10-3mm2/s] and grade IV [(0.797±0.156)×10-3mm2/s] tumors (P〈0.001). But there was no significant difference between the mean value of minADC of grade III and that of grade IV tumors (P=0.069). There was significant negative correlation between minADC and different tumor grades (r=-0.699, P〈0.001). Conclusion: The minADC is useful for prediction of glioma grade.
出处 《中国医学计算机成像杂志》 CSCD 北大核心 2013年第6期477-480,共4页 Chinese Computed Medical Imaging
基金 国家自然科学基金(No.81071132) 上海市科委生物医药处医学重点项目(No.10411952100) 上海市教委科技创新重点项目(No.12ZZ003)~~
关键词 磁共振成像 弥散加权成像 表面弥散系数 胶质瘤 Magnetic resonance imaging Diffusion magnetic resonance imaging Apparent diffusion coefficient Glioma
  • 相关文献

参考文献3

二级参考文献27

  • 1Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 2007, 114:97-109.
  • 2Calvar JA, Meli FJ, Romero C, et al. Characterization of brain tumors by MRS, DWI and Kil-67 labeling index. J Neurooncol, 2005, 72:273-280.
  • 3Higano S, Yun X, Kumabe T, et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology, 2006, 241:839-846.
  • 4Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion- weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging, 1999,9:53-60.
  • 5Torp SH. Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies. Clin Neuropathol, 2002, 21:252-257.
  • 6King AD, Ahuja AT, Yeung DK, et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging.Radiology, 2007, 245 : 806-813.
  • 7Charles-Edwards EM, deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging, 2006, 6: 135-143.
  • 8Hayashida Y, Hirai T, Morishita S, et al. Diffusion-weighted imaging of metastatic brain tumors : comparison with histologic type and tumor cellularity. AJNR, 2006, 27: 1419-1425.
  • 9Guo AC, Cummings TJ, Dash RC, et al. Lymphomas and high- grade astrocytomas : comparison of water diffusibility and histologic characteristics. Radiology, 2002, 224 : 177-183.
  • 10Gupta RK, Cloughesy TF, Sinha U, et al. Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol, 2000, 50: 215-226.

共引文献36

同被引文献98

  • 1韩彤,崔世民.SWI原理及其在脑肿瘤评估和胶质瘤分级中的应用[J].国际医学放射学杂志,2011,34(1):15-20. 被引量:13
  • 2Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 2007, 114: 97-109.
  • 3Nezamzadeh M, Matson GB, Young K, et al. Improved pseudo- continuous arterial spin labeling for mapping brain perfusion. J Magn Reson Imaging, 2010, 31: 1419-1427.
  • 4Wu WC, Fern-~indez SM, Detre JA, et al. A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med, 2007, 58: 1020-1027.
  • 5Sugahara T, Korogi Y, Kochi M, et al. Usefulness of diffusion- weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. JMagnResonImaging, 1999, 9:53-60.
  • 6Lam W, Poon W, Metreweli C. Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma? Clin Radiol, 2002;57:219-225.
  • 7Chaskis C, Stadnik T, Michotte A, et al. Prognostic value of perfusion-weighted imaging in brain glioma: a prospective study. Acta Neurochir, 2006, 14: 277-285.
  • 8Plate KH, Breier G, Risau W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol, 1994, 4: 207- 218.
  • 9Korkolopoulou P, Patsouris E, Kavantzas N, et al. Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol, 2002, 28: 57-66.
  • 10Hirai T, Kitajima M, Nakamura H, et al. Quantitative blood flow measurements in gliomas using arterial spin-labeling at 3T: intermodality agreement and inter-and intraobserver reproducibility study. AJNR Am J Neuroradiol, 2011, 32:2073-2079.

引证文献13

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部